|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Metacrine (NASDAQ: MTCR) through any online brokerage.
There are no as such competitors for Metacrine.
The latest price target for Metacrine (NASDAQ: MTCR) was reported by Canaccord Genuity on October 22, 2021. The analyst firm set a price target for 1.00 expecting MTCR to fall to within 12 months (a possible -30.56% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Metacrine (NASDAQ: MTCR) is $1.44 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Metacrine.
Metacrine’s $Q3 earnings are confirmed for after-market on $November 11, 2021.
There is no upcoming split for Metacrine.
Metacrine is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.